Financials
- Market Capitalization 2.39 B
- Employee 540
- Founded 2008
- CEO N/A
- Website www.agios.com
- Headquarter Delaware, United States
- FIGI BBG000QY4ZD0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.82
Relación precio/flujo de caja
29.21
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1885 | VCEL Vericel Corporation - Common Stock | 45.82 USD | -3.52% | -1.82% | +20.99% | +26.05% | 2.34 B USD | ||
| 1887 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.23 USD | +4.83% | +0.68% | +67.47% | +571.57% | 2.46 B USD | ||
| 1890 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.70 USD | +7.14% | -10.15% | +22.83% | +151.78% | 2.51 B USD | ||
| 1896 | NKTR Nektar Therapeutics - Common Stock | 69.00 USD | +1.00% | -9.53% | +14.48% | -5.83% | 2.33 B USD |